GO:0044375 regulation of peroxisome size: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0044375 (regulation of peroxisome size) is a biological process that modulates the volume of peroxisomes, which are small, membrane-bounded organelles that use dioxygen to oxidize organic molecules.
• Peroxisome size is dynamically controlled by the balance between peroxisome biogenesis, division, and degradation, and is influenced by metabolic cues such as fatty acid beta-oxidation.
• Key proteins involved in peroxisome size regulation include PEX11 family members, dynamin-related proteins (e.g., Dnm1), and fission machinery components, as well as metabolic enzymes like acyl-CoA oxidases.
• Phosphorylation of peroxisomal proteins is an important regulatory mechanism controlling peroxisome dynamics, including size and number.
• Alterations in peroxisome size and function are linked to human diseases, including peroxisomal biogenesis disorders (e.g., Zellweger syndrome) and metabolic disorders.
• Experimental approaches to study peroxisome size regulation include fluorescence microscopy, electron microscopy, genetic screens in yeast, and CRISPR-based genome editing in mammalian cells.
Description
Peroxisomes are ubiquitous, single-membrane organelles that carry out essential oxidative reactions, including fatty acid beta-oxidation and hydrogen peroxide metabolism. The size of peroxisomes is not fixed; it changes in response to developmental and metabolic signals, and this dynamic regulation is critical for cellular homeostasis. The Gene Ontology term GO:0044375, regulation of peroxisome size, describes any process that modulates the volume of a peroxisome. Understanding how peroxisome size is controlled is important because defects in peroxisome dynamics contribute to a range of human diseases, from inherited peroxisomal disorders to metabolic and neurodegenerative conditions. Research in model organisms such as the yeast Yarrowia lipolytica has shown that peroxisome size and number are regulated by fatty acid beta-oxidation activity, linking organelle morphology to metabolic state. Moreover, phosphorylation events on peroxisomal proteins add another layer of regulation, affecting peroxisome dynamics. This article provides a research-grade overview of GO:0044375, covering its definition, biological significance, key genes, regulatory mechanisms, disease connections, and experimental methods for study.
regulation of peroxisome size At A Glance
| GO ID | GO:0044375 |
|---|---|
| GO term | regulation of peroxisome size |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the volume of peroxisomes, influencing organelle capacity for oxidative metabolism |
| Related processes | Peroxisome organization, peroxisome fission, peroxisome fusion, peroxisome degradation |
| Key regulators | PEX11 family proteins, dynamin-related proteins, phosphorylation events |
| Disease relevance | Peroxisomal biogenesis disorders, metabolic dysfunction |
What Is GO:0044375?
GO:0044375, regulation of peroxisome size, is defined as any process that modulates the volume of a peroxisome, a small, membrane-bounded organelle that uses dioxygen (O2) to oxidize organic molecules. In other words, it encompasses the cellular mechanisms that control how large or small peroxisomes become, including changes in membrane expansion, fission, fusion, and degradation.
Why Is regulation of peroxisome size Important in Cell Biology?
Regulation of peroxisome size is crucial for cellular adaptation to metabolic demands, as peroxisomes house essential oxidative reactions including fatty acid beta-oxidation and detoxification of hydrogen peroxide. Changes in peroxisome size can affect the organelle's surface area-to-volume ratio, thereby influencing the efficiency of metabolite exchange and enzymatic reactions. Dysregulation of peroxisome size has been observed in various pathological states, including peroxisomal biogenesis disorders and metabolic diseases, making it a topic of significant biomedical interest.
• Peroxisome size regulation is essential for normal lipid metabolism, including fatty acid beta-oxidation.
• It impacts cellular redox balance by modulating the capacity for hydrogen peroxide decomposition.
• Altered peroxisome size is a hallmark of peroxisomal biogenesis disorders such as Zellweger syndrome.
• Peroxisome size changes are associated with metabolic diseases like obesity and diabetes.
• Regulation of peroxisome size is linked to cell division and proliferation, as peroxisomes must be distributed properly during mitosis.
• Phosphorylation of peroxisomal proteins provides a dynamic switch for controlling peroxisome size and number.
• Understanding peroxisome size regulation can inform therapeutic strategies for peroxisomal and metabolic disorders.
• Yeast models have been instrumental in identifying conserved regulators of peroxisome size, such as PEX11.
• Peroxisome size affects the organelle's ability to interact with other organelles, including mitochondria and lipid droplets.
• Experimental manipulation of peroxisome size may offer insights into aging and age-related diseases.
What Happens During regulation of peroxisome size?
Peroxisome Biogenesis and Membrane Expansion
In simple terms: Peroxisomes grow by adding new membrane and proteins.
Peroxisome size regulation begins with the biogenesis of the organelle, which involves the import of matrix and membrane proteins from the cytosol. The peroxin (PEX) proteins mediate the assembly of the peroxisomal membrane and the import of cargo, leading to membrane expansion and an increase in organelle volume. This process is tightly linked to the availability of metabolic substrates, such as fatty acids, which can induce peroxisome proliferation.
Peroxisome Division and Fission
In simple terms: Peroxisomes split into smaller ones to control their size.
Peroxisome size is also regulated by division, a process that requires the constriction and fission of the peroxisomal membrane. Key players include PEX11 family proteins, which are thought to induce membrane curvature, and dynamin-related proteins (DRPs) such as Dnm1 in yeast, which execute the fission event. The balance between growth and division determines the steady-state size of peroxisomes.
Peroxisome Degradation and Turnover
In simple terms: Old or excess peroxisomes are broken down to keep size in check.
Peroxisome size can be reduced through degradation pathways, including pexophagy, a selective form of autophagy that targets peroxisomes for lysosomal or vacuolar degradation. This removal of entire organelles or portions of them contributes to the regulation of peroxisome volume and number, especially under conditions of nutrient stress or metabolic remodeling.
Metabolic Feedback and Signaling
In simple terms: The cell senses metabolic needs and adjusts peroxisome size accordingly.
Metabolic signals, such as fatty acid levels, can modulate peroxisome size by altering the expression of peroxisomal genes and the activity of regulatory proteins. For example, in the yeast Yarrowia lipolytica, fatty acid beta-oxidation activity regulates peroxisome size and number. Additionally, phosphorylation of peroxisomal proteins, such as PEX11, can affect peroxisome dynamics in response to cellular signals.
Role of Phosphorylation in Peroxisome Dynamics
In simple terms: Adding phosphate groups to proteins can change peroxisome size.
Phosphorylation is a reversible post-translational modification that regulates many aspects of peroxisome biology. Proteomic studies have identified phosphorylation sites on peroxisomal proteins, including PEX11 and other peroxins, suggesting that kinases and phosphatases control peroxisome size and proliferation. This adds a layer of dynamic regulation that allows rapid adjustments to organelle morphology.
Key Genes Involved in GO:0044375 regulation of peroxisome size
The following genes and proteins have been implicated in the regulation of peroxisome size, based on experimental evidence from model organisms and human studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PEX11A | Promotes peroxisome elongation and division | Key regulator of peroxisome size and abundance; studied in yeast and mammals |
| PEX11B | Involved in peroxisome membrane remodeling and fission | Mutations linked to peroxisomal disorders; target for size regulation studies |
| PEX11G | Peroxisomal membrane protein that induces membrane curvature | Less characterized; potential role in size control |
| DNM1L | Dynamin-related protein that mediates peroxisomal fission | Essential for division; mutations cause neurodevelopmental disorders |
| FIS1 | Adaptor protein recruiting DRPs to peroxisomes | Regulates fission and size; studied in yeast and human cells |
| MFF | Mitochondrial fission factor, also involved in peroxisomal fission | Links peroxisome and mitochondrial dynamics |
| PEX5 | Peroxisomal targeting signal 1 receptor | Required for matrix protein import; affects peroxisome size indirectly |
| PEX7 | Peroxisomal targeting signal 2 receptor | Defects cause rhizomelic chondrodysplasia punctata; impacts peroxisome function |
| ACOX1 | Acyl-CoA oxidase 1, first enzyme of fatty acid beta-oxidation | Its activity influences peroxisome size in yeast |
| ACOX2 | Acyl-CoA oxidase 2 | Involved in bile acid synthesis; may affect peroxisome metabolism |
| CAT | Catalase, detoxifies hydrogen peroxide | Abundant peroxisomal enzyme; its import affects organelle volume |
| PPARA | Peroxisome proliferator-activated receptor alpha | Transcription factor that induces peroxisome proliferation and size increase |
| YAP1 | Yes-associated protein 1, transcriptional co-activator | Mediates PPARα-induced hepatomegaly and may influence peroxisome size |
| TEAD1 | TEA domain transcription factor 1 | Partners with YAP to regulate gene expression; linked to peroxisome proliferation |
| SIRT1 | NAD-dependent deacetylase sirtuin 1 | May regulate peroxisome size through metabolic signaling |
| PEX3 | Peroxisomal membrane assembly protein | Essential for peroxisome biogenesis; affects size |
| PEX16 | Peroxisomal membrane protein involved in biogenesis | Mutations cause peroxisomal disorders; impacts organelle size |
How Is regulation of peroxisome size Regulated?
Regulation of peroxisome size is controlled at multiple levels, including transcriptional, post-translational, and metabolic feedback mechanisms. The transcription factor PPARα (peroxisome proliferator-activated receptor alpha) is a master regulator of peroxisome proliferation, and its activation leads to increased peroxisome size and number in response to fatty acids or fibrate drugs. The YAP-TEAD pathway has been shown to mediate PPARα-induced hepatomegaly and liver regeneration, suggesting a link between peroxisome size regulation and organ growth. Phosphorylation of peroxisomal proteins, such as PEX11, by yet-to-be-identified kinases provides a rapid mechanism to modulate peroxisome dynamics. Additionally, sirtuin activators may influence peroxisome size through effects on cellular metabolism and stress responses.
regulation of peroxisome size and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PEX11B | Peroxisomal biogenesis disorder | Knockout in HeLa cells; rescue with wild-type or mutant PEX11B |
| DNM1L | Neurodevelopmental disorder with peroxisomal fission defects | Patient-derived fibroblasts; CRISPR knockout in SH-SY5Y cells |
| PPARA | Metabolic syndrome, hepatomegaly | Liver-specific knockout mice; overexpression in hepatocytes |
| ACOX1 | Peroxisomal beta-oxidation deficiency | Yeast Yarrowia lipolytica knockout; mammalian cell models |
| SIRT1 | Aging, metabolic dysfunction | SIRT1 activator treatment in cell culture; knockout mice |
Peroxisomal Biogenesis Disorders
Mutations in PEX genes cause peroxisomal biogenesis disorders, such as Zellweger syndrome spectrum, which are characterized by defective peroxisome assembly and often altered peroxisome size and number. These disorders lead to severe neurological, hepatic, and skeletal abnormalities, highlighting the importance of proper peroxisome size regulation for human health.
Metabolic Diseases
Alterations in peroxisome size and function have been observed in metabolic diseases including obesity, insulin resistance, and non-alcoholic fatty liver disease. The interplay between peroxisome dynamics and lipid metabolism suggests that targeting peroxisome size regulation could have therapeutic potential for metabolic disorders.
Neurodegeneration
Peroxisomal dysfunction is linked to neurodegenerative diseases such as X-linked adrenoleukodystrophy and possibly Alzheimer's disease. Proper regulation of peroxisome size is essential for neuronal health, as peroxisomes play critical roles in lipid metabolism and redox balance in the brain.
Cancer
Emerging evidence suggests that peroxisome dynamics can influence cancer cell metabolism and proliferation. The YAP-TEAD pathway, which mediates PPARα-induced hepatomegaly, is also implicated in cancer, indicating a potential connection between peroxisome size regulation and tumorigenesis.
From regulation of peroxisome size-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate peroxisome size? | CRISPR knockout of gene X in HeLa or HepG2 cells, followed by microscopy |
| What is the effect of a point mutation in PEX11B on peroxisome size? | Knock-in of mutant PEX11B using CRISPR in patient fibroblasts |
| How does overexpression of PPARα affect peroxisome size? | Lentiviral overexpression of PPARα in hepatocytes |
| Does phosphorylation of PEX11 regulate peroxisome size? | Phospho-mutant knock-in of PEX11 at specific serine residues |
| What is the role of ACOX1 in peroxisome size? | Knockout of ACOX1 in Yarrowia lipolytica and measurement of peroxisome size |
| Can we visualize peroxisome dynamics in real time? | Tagged knock-in of PEX11 with fluorescent protein (e.g., GFP) |
How to Study the regulation of peroxisome size Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Peroxisome size, number, and dynamics | Live-cell imaging of PEX11-GFP in HeLa cells |
| Electron microscopy | Ultrastructure and precise size of peroxisomes | Quantification of peroxisome diameter in patient fibroblasts |
| Yeast genetic screen | Identification of genes affecting peroxisome size | Screening deletion library in Yarrowia lipolytica |
| Phosphoproteomics | Phosphorylation sites on peroxisomal proteins | Mapping PEX11 phosphorylation after kinase activation |
| RNA-seq | Transcriptional changes in peroxisomal genes | PPARα activation in hepatocytes |
| CRISPR knockout | Loss-of-function effects on peroxisome size | Knockout of PEX11B in HeLa cells |
| CRISPR knock-in | Effect of specific mutations on peroxisome size | Introduction of phospho-mutant PEX11 |
| Overexpression | Gain-of-function effects on peroxisome size | Overexpression of PPARα in liver cells |
Fluorescence Microscopy
Fluorescence microscopy, often using fluorescently tagged peroxisomal markers such as PEX11-GFP or catalase-GFP, allows visualization and quantification of peroxisome size and number in live or fixed cells. This method is widely used to assess changes in peroxisome morphology upon genetic or pharmacological perturbations.
Electron Microscopy
Transmission electron microscopy (TEM) provides high-resolution images of peroxisomes, enabling precise measurement of organelle size and ultrastructure. TEM is considered the gold standard for peroxisome identification and size determination.
Genetic Screens in Yeast
Yeast models, such as Saccharomyces cerevisiae and Yarrowia lipolytica, have been used in genetic screens to identify genes regulating peroxisome size and number. These screens have uncovered conserved components of the peroxisome division machinery, including PEX11 and dynamin-related proteins.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics and phosphoproteomics can identify post-translational modifications on peroxisomal proteins, revealing regulatory phosphorylation events that control peroxisome dynamics. This approach helps map signaling pathways that modulate peroxisome size.
How CRISPR Can Be Used to Study GO:0044375 regulation of peroxisome size
Knockout
CRISPR knockout is used to delete genes suspected to regulate peroxisome size, such as PEX11B or DNM1L, in cell lines like HeLa or HepG2. Following knockout, peroxisome size can be measured by fluorescence microscopy or electron microscopy to determine the gene's role.
Point Mutation
CRISPR point mutation (base editing or homology-directed repair) allows the introduction of specific amino acid substitutions, for example in PEX11 phosphorylation sites, to test their impact on peroxisome size and dynamics.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or disease-associated mutations into endogenous loci enables real-time visualization of peroxisomes and study of mutant effects on organelle size.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can be used to increase the expression of genes like PPARα or PEX11 to study their effects on peroxisome size and proliferation.
How EDITGENE Supports regulation of peroxisome size Research
Researchers studying regulation of peroxisome size-related genes often need to determine whether a candidate gene is causally involved in peroxisome dynamics. EDITGENE provides a comprehensive suite of CRISPR-based services to facilitate these investigations, from gene knockout to precise point mutations and overexpression, enabling robust functional studies in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for regulation of peroxisome size research.
Frequently Asked Questions About regulation of peroxisome size
What is GO:0044375 regulation of peroxisome size?
GO:0044375 is a Gene Ontology biological process term defined as any process that modulates the volume of a peroxisome, a small, membrane-bounded organelle that uses dioxygen to oxidize organic molecules.
What genes are involved in regulation of peroxisome size?
Key genes include PEX11 family members (PEX11A, PEX11B, PEX11G), DNM1L, FIS1, MFF, and metabolic genes like ACOX1 and PPARA.
How is peroxisome size regulated?
Peroxisome size is regulated by a balance of biogenesis, division (fission), and degradation (pexophagy), as well as by metabolic and phosphorylation signals.
Why is regulation of peroxisome size important?
It is crucial for metabolic adaptation, lipid homeostasis, and cellular redox balance; dysregulation is linked to peroxisomal disorders and metabolic diseases.
What diseases are associated with peroxisome size defects?
Peroxisomal biogenesis disorders (e.g., Zellweger syndrome), metabolic diseases like obesity and diabetes, and neurodegenerative conditions.
What methods are used to study peroxisome size?
Fluorescence microscopy, electron microscopy, yeast genetic screens, proteomics, and CRISPR-based genome editing.
Can CRISPR be used to study peroxisome size regulation?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models allow functional dissection of genes controlling peroxisome size.
What is the role of PEX11 in peroxisome size?
PEX11 proteins promote peroxisome elongation and division, thereby regulating organelle size and number.
How does phosphorylation affect peroxisome size?
Phosphorylation of peroxisomal proteins such as PEX11 can modulate peroxisome dynamics, including size and proliferation.
What model organisms are used to study peroxisome size?
Yeast such as Yarrowia lipolytica and Saccharomyces cerevisiae are widely used, along with mammalian cell lines and mouse models.
Conclusion
Regulation of peroxisome size (GO:0044375) is a dynamic and essential cellular process that impacts metabolism, redox balance, and organelle function. Research over the past decades has identified key regulators, including PEX11 family proteins, dynamin-related proteins, and phosphorylation events, and has linked peroxisome size defects to human diseases. Continued investigation using advanced CRISPR models and imaging techniques will further elucidate the mechanisms and therapeutic potential of targeting peroxisome size regulation.
References
- 1. Gregoire FM et al.. 1998. Understanding adipocyte differentiation.. Physiol Rev 78(3):783-809 PMID: 9674695
- 2. Fan S et al.. 2022. YAP-TEAD mediates PPAR α-induced hepatomegaly and liver regeneration in mice.. Hepatology 75(1):74-88 PMID: 34387904
- 3. Oeljeklaus S et al.. 2016. Regulation of peroxisome dynamics by phosphorylation.. Biochim Biophys Acta 1863(5):1027-37 PMID: 26775584
- 5. Smith JJ et al.. 2013. Peroxisomes take shape.. Nat Rev Mol Cell Biol 14(12):803-17 PMID: 24263361
- 6. Alcaín FJ et al.. 2009. Sirtuin activators.. Expert Opin Ther Pat 19(4):403-14 PMID: 19441923
- 7. Smith JJ et al.. 2000. Regulation of peroxisome size and number by fatty acid beta -oxidation in the yeast yarrowia lipolytica.. J Biol Chem 275(26):20168-78 PMID: 10787422
- 8. Yan M et al.. 2005. The control of peroxisome number and size during division and proliferation.. Curr Opin Cell Biol 17(4):376-83 PMID: 15978793
